Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8013 | 1227 | 29.7 | 67% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LIGHT CHAIN DEPOSITION DISEASE | Author keyword | 146 | 86% | 6% | 74 |
2 | CRYSTAL STORING HISTIOCYTOSIS | Author keyword | 45 | 83% | 2% | 25 |
3 | HEAVY CHAIN DEPOSITION DISEASE | Author keyword | 42 | 94% | 1% | 15 |
4 | MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE | Author keyword | 27 | 76% | 2% | 19 |
5 | CAST NEPHROPATHY | Author keyword | 27 | 66% | 2% | 25 |
6 | MYELOMA KIDNEY | Author keyword | 17 | 70% | 1% | 14 |
7 | BENCE JONES PROTEINS | Author keyword | 16 | 61% | 1% | 17 |
8 | LIGHT CHAIN NEPHROPATHY | Author keyword | 15 | 82% | 1% | 9 |
9 | LIGHT CHAIN DEPOSITION DISEASE LCDD | Author keyword | 12 | 75% | 1% | 9 |
10 | LIGHT CHAIN CAST NEPHROPATHY | Author keyword | 12 | 86% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CAST NEPHROPATHY | 90 | 77% | 5% | 61 |
2 | BENCE JONES PROTEINS | 47 | 39% | 8% | 95 |
3 | MONOCLONAL KAPPA CHAIN | 45 | 94% | 1% | 16 |
4 | HIGH CUTOFF HEMODIALYSIS | 32 | 85% | 1% | 17 |
5 | LIGHT CHAIN DEPOSITION | 28 | 57% | 3% | 33 |
6 | IMMUNOGLOBULIN DEPOSITION DISEASE | 25 | 73% | 2% | 19 |
7 | MIMICKING ADULT RHABDOMYOMA | 24 | 91% | 1% | 10 |
8 | CYTOPLASMIC CRYSTALS | 23 | 100% | 1% | 10 |
9 | CHAIN DEPOSITION DISEASE | 19 | 47% | 2% | 30 |
10 | MONOCLONAL IMMUNOGLOBULIN | 19 | 76% | 1% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Diagnosis of monoclonal gammopathy of renal significance | 2015 | 1 | 86 | 37% |
The pathogenesis and diagnosis of acute kidney injury in multiple myeloma | 2012 | 36 | 92 | 79% |
Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group | 2010 | 89 | 73 | 63% |
Pathogenesis and treatment of renal failure in multiple myeloma | 2008 | 93 | 65 | 77% |
Systemic Amyloidoses | 2013 | 22 | 112 | 33% |
Current treatments for renal failure due to multiple myeloma | 2013 | 8 | 99 | 75% |
Kidney Disease and Multiple Myeloma | 2013 | 8 | 93 | 51% |
Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: A single center experience | 2011 | 13 | 38 | 63% |
Novel Therapeutic Agents for the Management of Patients with Multiple Myeloma and Renal Impairment | 2012 | 12 | 82 | 56% |
Novel approaches for reducing free light chains in patients with myeloma kidney | 2012 | 7 | 70 | 79% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN IMMUNOL CANC PROGRAM | 3 | 21% | 1.1% | 13 |
2 | NEPHROL TRAINING FREE RADICAL BIOL | 2 | 67% | 0.2% | 2 |
3 | RENAL BIRMINGHAM | 2 | 17% | 0.8% | 10 |
4 | BIOQUIM ONANCIA MAGNET NUCL | 1 | 50% | 0.2% | 2 |
5 | EP118 | 1 | 100% | 0.2% | 2 |
6 | GERRY AMYLOID | 1 | 100% | 0.2% | 2 |
7 | MULTIPLE MYELOMA BEIJING | 1 | 50% | 0.2% | 2 |
8 | NEPHROL TRAINING FREE RAD BIOL | 1 | 50% | 0.2% | 2 |
9 | UTHLTH SCI HOUSTON | 1 | 100% | 0.2% | 2 |
10 | UMR S 702 | 1 | 15% | 0.7% | 8 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000209401 | MU HEAVY CHAIN DISEASE//HEAVY CHAIN DISEASE//GAMMA HEAVY CHAIN DISEASE |
2 | 0.0000151485 | FIBRILLARY GLOMERULONEPHRITIS//NAIL PATELLA SYNDROME//IMMUNOTACTOID GLOMERULOPATHY |
3 | 0.0000145563 | IMMUNOFIXATION ELECTROPHORESIS//FREE LIGHT CHAINS//SERUM FREE LIGHT CHAINS |
4 | 0.0000125706 | AMYLOIDOSIS//AL AMYLOIDOSIS//AMYLOIDOMA |
5 | 0.0000098831 | MULTIPLE MYELOMA//LENALIDOMIDE//BORTEZOMIB |
6 | 0.0000063118 | PLASMACYTOMA//EXTRAMEDULLARY PLASMACYTOMA//SOLITARY PLASMACYTOMA |
7 | 0.0000062013 | IMMUNOLOGICAL SIGNAL//BIOINFORMAT TELEMED//INTERDISCIPLINARY MODELING |
8 | 0.0000058177 | MOTT CELL//RUSSELL BODIES//MOTT CELLS |
9 | 0.0000050449 | WALDENSTROMS MACROGLOBULINEMIA//WALDENSTROM MACROGLOBULINEMIA//BING WALDENSTROMS MACROGLOBULINEMIA |
10 | 0.0000045452 | RENAL LYMPHOMA//PRIMARY RENAL LYMPHOMA//PARANEOPLASTIC NEPHROTIC SYNDROME |